Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2015

Khan Sofia, Fagerholm Rainer, Rafiq Sajjad, Tapper William, Aittomäki Kristiina, Liu Jianjun, Blomqvist Carl, Eccles Diana, Nevanlinna Heli

Abstract excerpt

PURPOSE: Although most patients with estrogen receptor (ER)-positive breast cancer benefit from endocrine therapies, a significant proportion do not. Our aim was to identify inherited genetic variations that might predict survival among patients receiving adjuvant endocrine therapies. EXPERIMENTAL DESIGN: We performed a meta-analysis of two genome-wide studies; Helsinki Breast Cancer Study, 805 patients, with 240...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Chromosomes, Human, Pair 19

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Homozygote

Share to Kaplan-Meier Estimate

Share to Multivariate Analysis

Share to Proportional Hazards Models

Share to Receptors, Estrogen

Source

Open in PubMed Open full text

Identifiers

PMID: 25964295
DOI: 10.1158/1078-0432.CCR-15-0296
PMCID: PMC4574404

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy.PMID 25964295Read ↗

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.Semantic proximity Read ↗

Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.Semantic proximity Read ↗

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.Semantic proximity Read ↗

Common variants at 19p13 are associated with susceptibility to ovarian cancer.Semantic proximity Read ↗

Identification of novel genetic markers of breast cancer survival.Semantic proximity Read ↗

Genome-wide association studies identify four ER negative-specific breast cancer risk loci.Semantic proximity Read ↗

The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.Semantic proximity Read ↗

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.Semantic proximity Read ↗

11q13 is a susceptibility locus for hormone receptor positive breast cancer.Semantic proximity Read ↗

Functional variants at the 21q22.3 locus involved in breast cancer progression identified by screening of genome-wide estrogen response elements.Semantic proximity Read ↗

The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.Semantic proximity Read ↗

Common breast cancer susceptibility loci are associated with triple-negative breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.